信息搜索
信息关键字:医药
 

共有1602条记录

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]

·医药生物行业周报:低估值提供安全边际,医保谈判提供边际变量2023-11-12 14:47:46
·医药板块牛股辈出 集采边际影响减弱市场回暖2023-11-11 2:09:57
·毕得医药:发布关于计划使用闲置自有资金进行现金管理公告2023-11-10 23:39:36
·鲁抗医药:公司注射用哌拉西林钠他唑巴坦钠通过仿制药一致性评价2023-11-10 21:15:37
·突发利好,医药商业板块逆市上涨!纯碱期货早盘逼近涨停,公司回应减产传闻2023-11-10 13:04:30
·医药行业2023年11月投资月报:医药持仓环比有所提升,精选底部个股2023-11-10 12:21:59
·万邦医药(301520)11月9日主力资金净卖出2119.84万元2023-11-10 11:01:24
·看好医药成长空间,百亿级私募布局热情高2023-11-10 6:21:40
·基金经理看涨后市 医药和电子板块最受关注2023-11-10 4:45:27
·恒瑞医药:公司钠钾镁钙葡萄糖注射液通过仿制药质量和疗效一致性评价2023-11-10 0:06:45
·创新药板块持续回暖 再鼎医药第三季度产品总收入同比增超20%2023-11-9 18:34:27
·上海医药:控股子公司的四款注射液通过仿制药一致性评价2023-11-9 17:44:06
·仟源医药(300254)11月9日主力资金净卖出244.69万元2023-11-9 15:53:55
·收评:沪指缩量微涨,传媒、医药等板块走低,煤炭板块拉升2023-11-9 15:22:58
·和黄医药宣布武田取得FRUZAQLA (呋喹替尼) 的美国FDA批准用于治疗经治转移性结直肠癌2023-11-9 8:40:38
·博瑞医药(688166)11月8日主力资金净买入3095.74万元2023-11-9 8:16:09
·11月份以来近九成医药主题基金实现正收益2023-11-9 0:54:44
·四川多家医药生物上市公司有产品拟中选第九批国家药品集采 “光脚”品种或将贡献增量收入2023-11-8 20:32:15
·股票行情快报:迪哲医药(688192)11月8日主力资金净卖出256.70万元2023-11-8 20:23:54
·2023三季度医药行业业绩总结:外部干扰陆续平复,业绩陆续体现公司主业稳健运营2023-11-8 18:42:29

分页[首页] [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81]